Literature DB >> 23764095

Inflammation, coronary flow reserve, and microvascular dysfunction: moving beyond cardiac syndrome X.

Viviany R Taqueti, Paul M Ridker.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23764095      PMCID： PMC3962806          DOI： 10.1016/j.jcmg.2013.02.005

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN： 1876-7591


× No keyword cloud information.
  24 in total

1.  Improved cardiac risk assessment with noninvasive measures of coronary flow reserve.

Authors:  Venkatesh L Murthy; Masanao Naya; Courtney R Foster; Jon Hainer; Mariya Gaber; Gilda Di Carli; Ron Blankstein; Sharmila Dorbala; Arkadiusz Sitek; Michael J Pencina; Marcelo F Di Carli
Journal:  Circulation       Date:  2011-10-17       Impact factor: 29.690

2.  Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis.

Authors:  M Turiel; L Tomasoni; S Sitia; S Cicala; L Gianturco; C Ricci; F Atzeni; V De Gennaro Colonna; M Longhi; P Sarzi-Puttini
Journal:  Cardiovasc Ther       Date:  2010-10       Impact factor: 3.023

3.  Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia.

Authors:  Maria C Ziadi; Robert A Dekemp; Kathryn A Williams; Ann Guo; Benjamin J W Chow; Jennifer M Renaud; Terrence D Ruddy; Niroshi Sarveswaran; Rebecca E Tee; Rob S B Beanlands
Journal:  J Am Coll Cardiol       Date:  2011-08-09       Impact factor: 24.094

4.  Endothelial dysfunction as assessed by flow-mediated dilation in patients with cardiac syndrome X: role of inflammation.

Authors:  P Tondi; A Santoliquido; A Di Giorgio; A Sestito; G A Sgueglia; R Flore; G Careri; G Pinnacchio; G A Lanza; F Crea
Journal:  Eur Rev Med Pharmacol Sci       Date:  2011-09       Impact factor: 3.507

5.  Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging.

Authors:  Kenji Fukushima; Mehrbod S Javadi; Takahiro Higuchi; Riikka Lautamäki; Jennifer Merrill; Stephan G Nekolla; Frank M Bengel
Journal:  J Nucl Med       Date:  2011-04-15       Impact factor: 10.057

6.  Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).

Authors:  Paul M Ridker; Tom Thuren; Andrew Zalewski; Peter Libby
Journal:  Am Heart J       Date:  2011-09-14       Impact factor: 4.749

7.  Effect of ezetimibe-simvastatine over endothelial dysfunction in dyslipidemic patients: assessment by 13N-ammonia positron emission tomography.

Authors:  Erick Alexanderson; Leonardo García-Rojas; Moisés Jiménez; Rodrigo Jácome; Rodrigo Calleja; Alfonso Martínez; Juan M Ochoa; Aloha Meave; Graciela Alexanderson
Journal:  J Nucl Cardiol       Date:  2010-08-25       Impact factor: 5.952

8.  Impaired coronary flow reserve in young patients affected by severe psoriasis.

Authors:  Elena Osto; Stefano Piaserico; Anna Maddalozzo; Giulia Forchetti; Roberta Montisci; Giulia Famoso; Andrea Giovagnoni; Andrea Peserico; Sabino Iliceto; Francesco Tona
Journal:  Atherosclerosis       Date:  2011-12-22       Impact factor: 5.162

9.  Coronary microvascular dysfunction is associated with higher frequency of thin-cap fibroatheroma.

Authors:  Saurabh S Dhawan; Michel T Corban; Ravi A Nanjundappa; Parham Eshtehardi; Michael C McDaniel; Collins A Kwarteng; Habib Samady
Journal:  Atherosclerosis       Date:  2012-06-19       Impact factor: 5.162

10.  Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus.

Authors:  Venkatesh L Murthy; Masanao Naya; Courtney R Foster; Mariya Gaber; Jon Hainer; Josh Klein; Sharmila Dorbala; Ron Blankstein; Marcelo F Di Carli
Journal:  Circulation       Date:  2012-08-23       Impact factor: 29.690
View more
  15 in total

Review 1.  Targeting the dominant mechanism of coronary microvascular dysfunction with intracoronary physiology tests.

Authors:  Hernán Mejía-Rentería; Nina van der Hoeven; Tim P van de Hoef; Julius Heemelaar; Nicola Ryan; Amir Lerman; Niels van Royen; Javier Escaned
Journal:  Int J Cardiovasc Imaging       Date:  2017-05-13       Impact factor: 2.357

2.  Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients.

Authors:  Navkaranbir S Bajaj; Michael T Osborne; Ankur Gupta; Ali Tavakkoli; Paco E Bravo; Tomas Vita; Courtney F Bibbo; Jon Hainer; Sharmila Dorbala; Ron Blankstein; Deepak L Bhatt; Marcelo F Di Carli; Viviany R Taqueti
Journal:  J Am Coll Cardiol       Date:  2018-08-14       Impact factor: 24.094

3.  Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization.

Authors:  Viviany R Taqueti; Rory Hachamovitch; Venkatesh L Murthy; Masanao Naya; Courtney R Foster; Jon Hainer; Sharmila Dorbala; Ron Blankstein; Marcelo F Di Carli
Journal:  Circulation       Date:  2014-11-16       Impact factor: 29.690

4.  Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction.

Authors:  Viviany R Taqueti; Scott D Solomon; Amil M Shah; Akshay S Desai; John D Groarke; Michael T Osborne; Jon Hainer; Courtney F Bibbo; Sharmila Dorbala; Ron Blankstein; Marcelo F Di Carli
Journal:  Eur Heart J       Date:  2018-03-07       Impact factor: 29.983

5.  Effects of sex on coronary microvascular dysfunction and cardiac outcomes.

Authors:  Venkatesh L Murthy; Masanao Naya; Viviany R Taqueti; Courtney R Foster; Mariya Gaber; Jon Hainer; Sharmila Dorbala; Ron Blankstein; Ornella Rimoldi; Paolo G Camici; Marcelo F Di Carli
Journal:  Circulation       Date:  2014-04-30       Impact factor: 29.690

Review 6.  Coronary Microvascular Dysfunction and Heart Failure with Preserved Ejection Fraction - implications for Chronic Inflammatory Mechanisms.

Authors:  Katie Anne Fopiano; Sawan Jalnapurkar; Alec C Davila; Vishal Arora; Zsolt Bagi
Journal:  Curr Cardiol Rev       Date:  2022

7.  Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease.

Authors:  Viviany R Taqueti; Brendan M Everett; Venkatesh L Murthy; Mariya Gaber; Courtney R Foster; Jon Hainer; Ron Blankstein; Sharmila Dorbala; Marcelo F Di Carli
Journal:  Circulation       Date:  2014-12-05       Impact factor: 29.690

Review 8.  Stable Ischemic Heart Disease in Women.

Authors:  Kelly M T Schmidt; John Nan; Dawn C Scantlebury; Niti R Aggarwal
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-07

9.  Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction.

Authors:  Seung Hun Lee; Doosup Shin; Joo Myung Lee; Tim P van de Hoef; David Hong; Ki Hong Choi; Doyeon Hwang; Coen K M Boerhout; Guus A de Waard; Ji-Hyun Jung; Hernan Mejia-Renteria; Masahiro Hoshino; Mauro Echavarria-Pinto; Martijn Meuwissen; Hitoshi Matsuo; Maribel Madera-Cambero; Ashkan Eftekhari; Mohamed A Effat; Tadashi Murai; Koen Marques; Joon-Hyung Doh; Evald H Christiansen; Rupak Banerjee; Hyun Kuk Kim; Chang-Wook Nam; Giampaolo Niccoli; Masafumi Nakayama; Nobuhiro Tanaka; Eun-Seok Shin; Steven A J Chamuleau; Niels van Royen; Paul Knaapen; Bon Kwon Koo; Tsunekazu Kakuta; Javier Escaned; Jan J Piek
Journal:  J Am Heart Assoc       Date:  2022-04-27       Impact factor: 6.106

10.  Coronary vasomotor dysfunction in cancer survivors treated with thoracic irradiation.

Authors:  John D Groarke; Sanjay Divakaran; Anju Nohria; Joseph H Killoran; Sharmila Dorbala; Ruth M Dunne; Jon Hainer; Viviany R Taqueti; Ron Blankstein; Harvey J Mamon; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2020-07-20       Impact factor: 5.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.